Pathogenic germline variations in other cancer susceptibility genes are also found to be associated with lung cancer risk including TP53 (i.e., Li‐Fraumeni syndrome), ATM [15, 16], BRAC2, and CHEK2 [17, 18]. This evidence concerns the gene TP53 and lung carcinoma.